The mission of the Stanford Center on Longevity is to redesign long life. The Center studies the nature and development of the human life span, looking for innovative ways to use science and technology to solve the problems of people over 50 by improving the well-being of people of all ages.
The Center on Longevity Corporate Affiliates program aims to engage with businesses and organizations across the United States and the world. Affiliates participate in the work of the Center on Longevity, building relationships with Stanford faculty and engaging in Center programs and activities. Longevity Corporate Affiliates support the Center’s mission, which facilitates and sustains leading edge research at Stanford.
The Stanford Center on Longevity expedites the transfer of knowledge from academia to the broader society. By bringing together academic experts, business leaders and policy makers, we ensure that the Center’s work is relevant, timely and responsive to the urgent realities of population aging.
The Center has three research divisions – Mind, Mobility and Financial Security. Over 140 Stanford faculty are research partners in the work of these divisions. Demographic analysis at the global, national and community level informs our work. The Center’s unique launch conferences and workshops bring together academic collaborators with business, government and non-profit leaders to find creative solutions to longevity challenges.
The Center was founded by Stanford professors Laura Carstensen PhD and Thomas Rando MD, PhD. A professor of psychology, founding director Laura Carstensen has won numerous awards, including a Guggenheim Fellowship, and her research has been supported for more than 20 years by the National Institute on Aging. Thomas Rando professor of neurology and neurological sciences, is deputy director. His research on aging has demonstrated that is possible to identify biochemical stimuli that can induce stem cells in old tissues to repair injuries as effectively as in young tissues. This work has broad implications for the fields of regenerative medicine and stem cell transplantation.